<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05069636</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-2021-519</org_study_id>
    <nct_id>NCT05069636</nct_id>
  </id_info>
  <brief_title>Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy</brief_title>
  <official_title>Lymphatic Osteopathic Manipulative Medicine to Enhance COVID-19 Vaccination Efficacy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rowan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rowan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to study the impact of Osteopathic Manipulative Medicine (OMM)&#xD;
      treatments, such as lymphatic myofascial release and thoracic pump techniques severe acute&#xD;
      respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels in patients who&#xD;
      receive the mRNA-1273 (Moderna) COVID-19 vaccine and to consider if these OMM strategies&#xD;
      allow a stronger more robust immune response.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>severe acute respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels</measure>
    <time_frame>The day of first vaccine dose (baseline), the day of second vaccine dose (at about 4-weeks post first vaccine dose), and 2-weeks post second vaccine dose (at about 6-weeks post first vaccine dose</time_frame>
    <description>Antibody levels collected via blood draw</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Lymphatic OMM plus Moderna COVID-19 Vaccine regimen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive OMM treatments that will include thoracic inlet and outlet myofascial release, pectoral traction myofascial release, and Miller Thoracic Lymphatic Pump technique plus the Moderna COVID-19 Vaccine regimen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Light Touch plus Moderna COVID-19 Vaccine regimen</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients receive a series of light touch techniques plus the Moderna COVID-19 Vaccine regimen.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lymphatic OMM</intervention_name>
    <description>Patients receive lymphatic myofascial release and thoracic pump techniques.</description>
    <arm_group_label>Lymphatic OMM plus Moderna COVID-19 Vaccine regimen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Light Touch</intervention_name>
    <description>Patients receive a series of light touch techniques.</description>
    <arm_group_label>Light Touch plus Moderna COVID-19 Vaccine regimen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria will include age greater than 18 years old and having safely&#xD;
             received the COVID-19 vaccine.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion criteria will include age under 18 years old, malignancy/cancer, ongoing&#xD;
             infection, coagulopathy history, use of anticoagulant medications, and fracture or&#xD;
             acute injury of the torso neck or upper extremities. Lymphatic OMM is safe during&#xD;
             pregnancy and this does not need to be an exclusion criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 29, 2021</study_first_submitted>
  <study_first_submitted_qc>October 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Osteopathic Manipulative Medicine</keyword>
  <keyword>Antibody</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

